MSA SAFETY INC Net Income (Loss) Available to Common Stockholders, Diluted
MSA SAFETY INC (MSA) reported Net Income (Loss) Available to Common Stockholders, Diluted of $86.17 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-31.
Financial Statements › Income Statement › Net Income
us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted · last filed 2026-07-31
- MSA SAFETY INC net income (loss) available to common stockholders, diluted for the quarter ending 2026-06-30 was $86.17M, a 37.32% increase year-over-year.
- MSA SAFETY INC net income (loss) available to common stockholders, diluted for the quarter ending 2026-03-31 was $71.25M, a 19.57% increase year-over-year.
- MSA SAFETY INC net income (loss) available to common stockholders, diluted for the quarter ending 2025-12-31 was $86.91M, a 1.16% decline year-over-year.
- MSA SAFETY INC net income (loss) available to common stockholders, diluted for the quarter ending 2025-09-30 was $69.60M, a 4.45% increase year-over-year.
- MSA SAFETY INC net income (loss) available to common stockholders, diluted for fiscal 2025 was $278.86M, a 2.12% decline from fiscal 2024.
- MSA SAFETY INC net income (loss) available to common stockholders, diluted for fiscal 2024 was $284.90M, a 386.88% increase from fiscal 2023.
- MSA SAFETY INC net income (loss) available to common stockholders, diluted for fiscal 2023 was $58.52M, a 67.41% decline from fiscal 2022.
- MSA SAFETY INC net income (loss) available to common stockholders, diluted for fiscal 2022 was $179.56M, a 743.99% increase from fiscal 2021.
| Period end | Net Income (Loss) Available to Common Stockholders, Diluted 3 month | Net Income (Loss) Available to Common Stockholders, Diluted 3 month as first filed | Net Income (Loss) Available to Common Stockholders, Diluted 6 month | Net Income (Loss) Available to Common Stockholders, Diluted 6 month as first filed | Net Income (Loss) Available to Common Stockholders, Diluted 9 month | Net Income (Loss) Available to Common Stockholders, Diluted 9 month as first filed | Net Income (Loss) Available to Common Stockholders, Diluted 12 month |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | $86.17M 10-Q · filed 2026-07-31 | $157.43M 10-Q · filed 2026-07-31 | $244.34M derived: sum of 3 quarters · filed 2026-07-31 | $313.94M derived: sum of 4 quarters · filed 2026-07-31 | |||
| 2026-03-31 | $71.25M 10-Q · filed 2026-05-05 | $158.17M derived: sum of 2 quarters · filed 2026-05-05 | $227.76M derived: sum of 3 quarters · filed 2026-05-05 | $290.52M derived: sum of 4 quarters · filed 2026-07-31 | |||
| 2025-12-31 | $86.91M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-12 | $156.51M derived: sum of 2 quarters · filed 2026-02-12 | $219.27M derived: sum of 3 quarters · filed 2026-07-31 | $278.86M 10-K · filed 2026-02-12 | |||
| 2025-09-30 | $69.60M 10-Q · filed 2025-10-29 | $132.35M derived: sum of 2 quarters · filed 2026-07-31 | $191.94M 10-Q · filed 2025-10-29 | $279.87M derived: sum of 4 quarters · filed 2026-07-31 | |||
| 2025-06-30 | $62.76M 10-Q · filed 2026-07-31 | $122.35M 10-Q · filed 2026-07-31 | $210.28M derived: sum of 3 quarters · filed 2026-07-31 | $276.91M derived: sum of 4 quarters · filed 2026-07-31 | |||
| 2025-03-31 | $59.59M 10-Q · filed 2026-05-05 | $147.52M derived: sum of 2 quarters · filed 2026-05-05 | $214.15M derived: sum of 3 quarters · filed 2026-05-05 | $286.37M derived: sum of 4 quarters · filed 2026-05-05 | |||
| 2024-12-31 | $87.93M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-12 | $154.56M derived: sum of 2 quarters · filed 2026-02-12 | $226.78M derived: sum of 3 quarters · filed 2026-02-12 | $284.90M 10-K · filed 2026-02-12 | |||
| 2024-09-30 | $66.63M 10-Q · filed 2025-10-29 | $138.85M derived: sum of 2 quarters · filed 2025-10-29 | $196.97M 10-Q · filed 2025-10-29 | $273.36M derived: sum of 4 quarters · filed 2026-02-12 | |||
| 2024-06-30 | $72.22M 10-Q · filed 2025-08-05 | $130.34M 10-Q · filed 2025-08-05 | $206.73M derived: sum of 3 quarters · filed 2026-02-12 | $271.97M derived: sum of 4 quarters · filed 2026-02-12 | |||
| 2024-03-31 | $58.12M 10-Q · filed 2025-05-01 | $134.51M derived: sum of 2 quarters · filed 2026-02-12 | $199.75M derived: sum of 3 quarters · filed 2026-02-12 | $266.82M derived: sum of 4 quarters · filed 2026-02-12 | |||
| 2023-12-31 | $76.39M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-12 | $141.63M derived: sum of 2 quarters · filed 2026-02-12 | $208.70M derived: sum of 3 quarters · filed 2026-02-12 | $58.52M 10-K · filed 2026-02-12 | |||
| 2023-09-30 | $65.24M 10-Q · filed 2024-10-24 | $132.31M derived: sum of 2 quarters · filed 2024-10-24 | -$17.87M 10-Q · filed 2024-10-24 | $33.60M derived: sum of 4 quarters · filed 2025-02-14 | |||
| 2023-06-30 | $67.07M 10-Q · filed 2024-07-25 | -$83.11M 10-Q · filed 2024-07-25 | -$31.64M derived: sum of 3 quarters · filed 2025-02-14 | $13.25M derived: sum of 4 quarters · filed 2025-02-14 | |||
| 2023-03-31 | -$150.18M 10-Q · filed 2024-04-30 | -$98.71M derived: sum of 2 quarters · filed 2025-02-14 | -$53.83M derived: sum of 3 quarters · filed 2025-02-14 | -$6.15M derived: sum of 4 quarters · filed 2025-02-14 | |||
| 2022-12-31 | $51.47M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-14 | $96.36M derived: sum of 2 quarters · filed 2025-02-14 | $144.03M derived: sum of 3 quarters · filed 2025-02-14 | $179.56M 10-K · filed 2025-02-14 | |||
| 2022-09-30 | $44.89M 10-Q · filed 2023-10-25 | $92.56M derived: sum of 2 quarters · filed 2023-10-25 | $128.09M 10-Q · filed 2023-10-25 | $66.61M derived: sum of 4 quarters · filed 2024-02-16 | |||
| 2022-06-30 | $47.67M 10-Q · filed 2023-08-01 | $83.20M 10-Q · filed 2023-08-01 | $21.72M derived: sum of 3 quarters · filed 2024-02-16 | $42.88M derived: sum of 4 quarters · filed 2024-02-16 | |||
| 2022-03-31 | $35.53M 10-Q · filed 2023-05-02 | -$25.96M derived: sum of 2 quarters · filed 2024-02-16 | -$4.79M derived: sum of 3 quarters · filed 2024-02-16 | $20.38M derived: sum of 4 quarters · filed 2024-02-16 | |||
| 2021-12-31 | -$61.49M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-16 | -$40.32M derived: sum of 2 quarters · filed 2024-02-16 | -$15.15M derived: sum of 3 quarters · filed 2024-02-16 | $21.27M 10-K · filed 2024-02-16 | |||
| 2021-09-30 | $21.17M 10-Q · filed 2022-10-27 | $18.81M 10-Q · filed 2021-10-29 | $46.34M derived: sum of 2 quarters · filed 2022-10-27 | $82.76M 10-Q · filed 2022-10-27 | $80.31M 10-Q · filed 2021-10-29 | $99.06M derived: sum of 4 quarters · filed 2023-02-16 | |
| 2021-06-30 | $25.17M 10-Q · filed 2022-07-28 | $25.11M 10-Q · filed 2021-07-29 | $61.59M 10-Q · filed 2022-07-28 | $61.50M 10-Q · filed 2021-07-29 | $77.89M derived: sum of 3 quarters · filed 2023-02-16 | $105.90M derived: sum of 4 quarters · filed 2023-02-16 | |
| 2021-03-31 | $36.43M 10-Q · filed 2022-04-29 | $36.39M 10-Q · filed 2021-04-29 | $52.72M derived: sum of 2 quarters · filed 2023-02-16 | $80.74M derived: sum of 3 quarters · filed 2023-02-16 | $116.76M derived: sum of 4 quarters · filed 2023-02-16 | ||
| 2020-12-31 | $16.30M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-16 | $44.31M derived: sum of 2 quarters · filed 2023-02-16 | $80.33M derived: sum of 3 quarters · filed 2023-02-16 | $123.95M 10-K · filed 2023-02-16 | |||
| 2020-09-30 | $28.01M 10-Q · filed 2021-10-29 | $64.03M derived: sum of 2 quarters · filed 2021-10-29 | $107.65M 10-Q · filed 2021-10-29 | $140.35M derived: sum of 4 quarters · filed 2022-02-18 | |||
| 2020-06-30 | $36.02M 10-Q · filed 2021-07-29 | $79.65M 10-Q · filed 2021-07-29 | $112.34M derived: sum of 3 quarters · filed 2022-02-18 | $154.48M derived: sum of 4 quarters · filed 2022-02-18 | |||
| 2020-03-31 | $43.63M 10-Q · filed 2021-04-29 | $76.31M derived: sum of 2 quarters · filed 2022-02-18 | $118.46M derived: sum of 3 quarters · filed 2022-02-18 | $158.20M derived: sum of 4 quarters · filed 2022-02-18 | |||
| 2019-12-31 | $32.68M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-18 | $74.83M derived: sum of 2 quarters · filed 2022-02-18 | $114.57M derived: sum of 3 quarters · filed 2022-02-18 | $137.77M 10-K · filed 2022-02-18 | |||
| 2019-09-30 | $42.14M 10-Q · filed 2020-10-30 | $81.89M derived: sum of 2 quarters · filed 2020-10-30 | $105.09M 10-Q · filed 2020-10-30 | ||||
| 2019-06-30 | $39.75M 10-Q · filed 2020-07-31 | $62.95M 10-Q · filed 2020-07-31 | |||||
| 2019-03-31 | $23.20M 10-Q · filed 2020-04-30 | ||||||
| 2018-09-30 | $33.67M 10-Q · filed 2019-10-24 | $66.81M derived: sum of 2 quarters · filed 2019-10-24 | $99.14M 10-Q · filed 2019-10-24 | ||||
| 2018-06-30 | $33.14M 10-Q · filed 2019-07-25 | $65.47M 10-Q · filed 2019-07-25 | |||||
| 2018-03-31 | $32.33M 10-Q · filed 2019-04-25 | ||||||
| 2017-09-30 | $32.02M 10-Q · filed 2018-10-25 | $44.53M derived: sum of 2 quarters · filed 2018-10-25 | $58.92M 10-Q · filed 2018-10-25 | ||||
| 2017-06-30 | $12.51M 10-Q · filed 2018-07-26 | $26.90M 10-Q · filed 2018-07-26 | |||||
| 2017-03-31 | $14.39M 10-Q · filed 2018-04-24 | ||||||
| 2013-09-30 | $19.35M 10-Q · filed 2013-10-23 | $43.22M derived: sum of 2 quarters · filed 2013-10-23 | $62.32M 10-Q · filed 2013-10-23 | $81.62M derived: sum of 4 quarters · filed 2013-10-23 | |||
| 2013-06-30 | $23.86M 10-Q · filed 2013-07-24 | $42.97M 10-Q · filed 2013-07-24 | $62.27M derived: sum of 3 quarters · filed 2013-07-24 | $81.32M derived: sum of 4 quarters · filed 2013-10-23 | |||
| 2013-03-31 | $19.11M 10-Q · filed 2013-04-24 | $38.41M derived: sum of 2 quarters · filed 2013-04-24 | $57.46M derived: sum of 3 quarters · filed 2013-10-23 | $85.18M derived: sum of 4 quarters · filed 2013-10-23 | |||
| 2012-12-31 | $19.30M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-20 | $38.35M derived: sum of 2 quarters · filed 2013-10-23 | $66.08M derived: sum of 3 quarters · filed 2013-10-23 | $89.73M 10-K · filed 2013-02-20 | |||
| 2012-09-30 | $19.05M 10-Q · filed 2013-10-23 | $46.78M derived: sum of 2 quarters · filed 2013-10-23 | $70.43M 10-Q · filed 2013-10-23 | $87.21M derived: sum of 4 quarters · filed 2013-10-23 | |||
| 2012-06-30 | $27.73M 10-Q · filed 2013-07-24 | $51.38M 10-Q · filed 2013-07-24 | $68.16M derived: sum of 3 quarters · filed 2013-07-24 | $87.91M derived: sum of 4 quarters · filed 2013-07-24 | |||
| 2012-03-31 | $23.65M 10-Q · filed 2013-04-24 | $40.44M derived: sum of 2 quarters · filed 2013-04-24 | $60.18M derived: sum of 3 quarters · filed 2013-04-24 | $79.55M derived: sum of 4 quarters · filed 2013-04-24 | |||
| 2011-12-31 | $16.78M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-20 | $36.53M derived: sum of 2 quarters · filed 2013-02-20 | $55.90M derived: sum of 3 quarters · filed 2013-02-20 | $69.06M 10-K · filed 2013-02-20 | |||
| 2011-09-30 | $19.75M 10-Q · filed 2012-10-24 | $39.11M derived: sum of 2 quarters · filed 2012-10-24 | $52.27M 10-Q · filed 2012-10-24 | $63.92M derived: sum of 4 quarters · filed 2012-10-24 | |||
| 2011-06-30 | $19.37M 10-Q · filed 2012-07-25 | $32.53M 10-Q · filed 2012-07-25 | $44.17M derived: sum of 3 quarters · filed 2012-07-25 | $53.67M derived: sum of 4 quarters · filed 2012-07-25 | |||
| 2011-03-31 | $13.16M 10-Q · filed 2012-04-25 | $24.81M derived: sum of 2 quarters · filed 2012-04-25 | $34.30M derived: sum of 3 quarters · filed 2012-04-25 | $46.00M derived: sum of 4 quarters · filed 2012-04-25 | |||
| 2010-12-31 | $11.65M derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-22 | $21.15M derived: sum of 2 quarters · filed 2012-02-22 | $32.84M derived: sum of 3 quarters · filed 2012-02-22 | $37.70M 10-K · filed 2013-02-20 | |||
| 2010-09-30 | $9.50M 10-Q · filed 2011-10-27 | $21.20M derived: sum of 2 quarters · filed 2011-10-27 | $26.05M 10-Q · filed 2011-10-27 | ||||
| 2010-06-30 | $11.70M 10-Q · filed 2011-07-28 | $16.55M 10-Q · filed 2011-07-28 | |||||
| 2009-12-31 | $42.93M 10-K · filed 2012-02-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ALIGN TECHNOLOGY INC (ALGN) | United States | $10.346B | 29.06 |
| ESTABLISHMENT LABS HOLDINGS INC. (ESTA) | $1.954B | -65.76 | |
| Cadre Holdings, Inc. (CDRE) | United States | $1.123B | 33.88 |
| Enovis CORP (ENOV) | United States | $1.053B | -1.18 |
| Anteris Technologies Global Corp. (AVR) | United States | $0.746B | |
| Sanara MedTech Inc. (SMTI) | United States | $0.323B | -6.81 |
| Inogen Inc (INGN) | United States | $0.139B | -7.00 |
| Conexeu Sciences Inc. (CNXU) | United States | $0.111B | |
| NutriBand Inc. (NTRB) | United States | $0.109B | |
| LAKELAND INDUSTRIES INC (LAKE) | United States | $0.104B | -4.21 |